Crescent Biopharma, Inc. (GLYC) at a glance

Crescent Biopharma, Inc. (GLYC) is a small-cap Healthcare company. It trades at $17.76. It does not pay a dividend. Vestovix scores it 49/100 overall. Its strongest dimension is Safety (66/100) and its weakest is Value (40/100).

Price
$17.76
Market cap
$1.16B
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$8.72 to $27.41
Vestovix Score49/ 100How this works
Value
40
Growth
50
Income
40
Safety
66
Momentum
48

Other Healthcare stocks

See all